Literature DB >> 23472659

The oncogene eIF4E: using biochemical insights to target cancer.

Martin Carroll1, Katherine L B Borden.   

Abstract

The eukaryotic translation initiation factor eIF4E is overexpressed in many human malignancies where it is typically a harbinger of poor prognosis. eIF4E is positioned as a nexus in post-transcriptional gene expression. To carry out these functions, eIF4E needs to bind the m(7)G cap moiety on mRNAs. It plays critical roles in mRNA translation, mRNA export, and most likely in mRNA stability as well. Through these activities, eIF4E coordinately modulates the expression of many transcripts involved in proliferation and survival. eIF4E function is controlled by interactions with protein cofactors in concert with many signaling pathways, including Ras, Mnk, Erk, MAPK, PI3K, mTOR, and Akt. This review describes the eIF4E activity and provides several examples of cellular control mechanisms. Further, we describe some therapeutic strategies in preclinical and clinical development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23472659      PMCID: PMC3653383          DOI: 10.1089/jir.2012.0142

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  135 in total

1.  Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.

Authors:  Ivan Topisirovic; Melisa Ruiz-Gutierrez; Katherine L B Borden
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

2.  Competitive PCR to detect eIF4E gene amplification in head and neck cancer.

Authors:  D L Sorrells; G E Ghali; C Meschonat; R J DeFatta; D Black; L Liu; A De Benedetti; C A Nathan; B D Li
Journal:  Head Neck       Date:  1999-01       Impact factor: 3.147

3.  Cooperative modulation by eIF4G of eIF4E-binding to the mRNA 5' cap in yeast involves a site partially shared by p20.

Authors:  M Ptushkina; T von der Haar; S Vasilescu; R Frank; R Birkenhäger; J E McCarthy
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

4.  Crystal structure of a minimal eIF4E-Cup complex reveals a general mechanism of eIF4E regulation in translational repression.

Authors:  Kerstin Kinkelin; Katharina Veith; Marlene Grünwald; Fulvia Bono
Journal:  RNA       Date:  2012-07-25       Impact factor: 4.942

5.  Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Authors:  H J Berkel; E A Turbat-Herrera; R Shi; A de Benedetti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

6.  Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.

Authors:  Nobuhiko Seki; Tasaburo Takasu; Koichi Mandai; Masao Nakata; Hideyuki Saeki; Yuji Heike; Ichiro Takata; Yoshihiko Segawa; Toshiaki Hanafusa; Kenji Eguchi
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

7.  Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies.

Authors:  C Tschopp; U Knauf; M Brauchle; M Zurini; P Ramage; D Glueck; L New; J Han; H Gram
Journal:  Mol Cell Biol Res Commun       Date:  2000-04

8.  Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.

Authors:  C A Nathan; L Liu; B D Li; F W Abreo; I Nandy; A De Benedetti
Journal:  Oncogene       Date:  1997-07-31       Impact factor: 9.867

9.  A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus.

Authors:  F Lejbkowicz; C Goyer; A Darveau; S Neron; R Lemieux; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

10.  Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.

Authors:  J-W Shih; T-Y Tsai; C-H Chao; Y-H Wu Lee
Journal:  Oncogene       Date:  2007-07-30       Impact factor: 9.867

View more
  41 in total

1.  A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E.

Authors:  Sarit Assouline; Biljana Culjkovic-Kraljacic; Julie Bergeron; Stephen Caplan; Eftihia Cocolakis; Caroline Lambert; Cara J Lau; Hiba Ahmad Zahreddine; Wilson H Miller; Katherine L B Borden
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

Review 2.  FXR1a-associated microRNP: A driver of specialized non-canonical translation in quiescent conditions.

Authors:  Syed I A Bukhari; Shobha Vasudevan
Journal:  RNA Biol       Date:  2016-12-02       Impact factor: 4.652

3.  Modified ARCA analogs providing enhanced translational properties of capped mRNAs.

Authors:  Ilona Kocmik; Karolina Piecyk; Magdalena Rudzinska; Anna Niedzwiecka; Edward Darzynkiewicz; Renata Grzela; Marzena Jankowska-Anyszka
Journal:  Cell Cycle       Date:  2018-08-17       Impact factor: 4.534

4.  4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice.

Authors:  Chunmei Wang; Antonio Cigliano; Lijie Jiang; Xiaolei Li; Biao Fan; Maria G Pilo; Yan Liu; Bing Gui; Marcella Sini; Jeffrey W Smith; Frank Dombrowski; Diego F Calvisi; Matthias Evert; Xin Chen
Journal:  Hepatology       Date:  2014-11-25       Impact factor: 17.425

Review 5.  Macromolecular transport between the nucleus and the cytoplasm: Advances in mechanism and emerging links to disease.

Authors:  Elizabeth J Tran; Megan C King; Anita H Corbett
Journal:  Biochim Biophys Acta       Date:  2014-08-09

6.  Integrin β6 can be translationally regulated by eukaryotic initiation factor 4E: Contributing to colonic tumor malignancy.

Authors:  Liu Enyu; Niu Zhengchuan; Wang Jiayong; Liang Benjia; Sun Qi; Qin Ruixi; Peng Cheng; Abdul Qadir Khan; Song Wei; Niu Jun
Journal:  Tumour Biol       Date:  2015-05-17

Review 7.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

8.  Targeting of protein translation as a new treatment paradigm for prostate cancer.

Authors:  Vidya P Ramamurthy; Senthilmurugan Ramalingam; Andrew K Kwegyir-Afful; Arif Hussain; Vincent C O Njar
Journal:  Curr Opin Oncol       Date:  2017-05       Impact factor: 3.645

9.  Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E.

Authors:  Laurent Volpon; Biljana Culjkovic-Kraljacic; Michael J Osborne; Anup Ramteke; Qingxiang Sun; Ashley Niesman; Yuh Min Chook; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

10.  Structural studies of the eIF4E-VPg complex reveal a direct competition for capped RNA: Implications for translation.

Authors:  Luciana Coutinho de Oliveira; Laurent Volpon; Amanda K Rahardjo; Michael J Osborne; Biljana Culjkovic-Kraljacic; Christian Trahan; Marlene Oeffinger; Benjamin H Kwok; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.